Sarepta Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
SRPT chart
What traders are saying about $SRPT
Latest postsSarepta Therapeutics, Inc. news
- Sarepta Therapeutics Sees Transformational 2027 as Rare Disease Programs Advance
marketbeat.com ·
- Sarepta Therapeutics stock quoted at EUR 15.99 in latest indication
ad-hoc-news.de ·
- Sarepta Therapeutics Inc (AB3A.HM) company profile and facts
Yahoo Finance Australia ·
- Is Sarepta Therapeutics (SRPT) Undervalued Following Raised 2026 Guidance And Mixed Quarterly Results?
Simply Wall St ·
- Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Sarepta Therapeutics, Inc. (SRPT) stock price, news, quote and history
Yahoo Finance Singapore ·
- What Is Behind The Rise In Moderna Stock?
trefis.com ·
- Learn Why The Bull Case For Sarepta Therapeutics Stock Could Change Following Raised Revenue Guidance
Yahoo Finance ·
- Will Narrower Losses Change Sarepta Therapeutics Stock Narrative
Simply Wall St ·
- Sarepta Therapeutics Inc (AB3A.HM) options chain
Yahoo Finance UK ·
- REGENXBIO Q3 Earnings Call Highlights
marketbeat.com ·
- Sarepta Therapeutics, Inc. (S1RP34.SA) Seasonal returns chart
Yahoo Finance UK ·
Sarepta Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.86B | $1.79B | $1.14B | $843.8M |
| Net income | -$713.4M | $235.2M | -$536.0M | -$703.5M |
| Diluted EPS | $-7.13 | $2.34 | $-5.80 | $-8.03 |
| Total assets (year end) | $3.35B | $3.96B | $3.26B | $3.13B |
| Cash and equivalents (year end) | $801.3M | $1.10B | $428.4M | $966.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Sarepta Therapeutics, Inc.
- Ticker
- SRPT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 873303
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
Frequently asked questions
What exchange is Sarepta Therapeutics, Inc. listed on?
Sarepta Therapeutics, Inc. trades on the Nasdaq under the ticker symbol SRPT.
What industry is Sarepta Therapeutics, Inc. in?
Sarepta Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Sarepta Therapeutics, Inc. headquartered?
Sarepta Therapeutics, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Sarepta Therapeutics, Inc.'s fiscal year end?
Sarepta Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Sarepta Therapeutics, Inc. report?
Sarepta Therapeutics, Inc. reported $1.86B in revenue for calendar year 2025, according to its SEC filings.